简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:Anheuser-Busch InBev NV is among 39 firms targeted by fresh European Union investigations into Belgian tax deals after an earlier order to recoup about 800 million euros ($885 million) was criticized by an EU court.
Anheuser-Busch InBev NV is among 39 firms targeted by fresh European Union investigations into Belgian tax deals after an earlier order to recoup about 800 million euros ($885 million) was criticized by an EU court.
The European Commission opened separate probes into so-called tax rulings that Belgian doled out to multinational companies from 2005 to 2014, it said in an emailed statement on Monday. The rulings “may have given a selective advantage” to the companies “allowing them to pay substantially less tax.”
The other companies targeted include BASF Antwerpen NV, BP Aromatics Limited NV, British American Tobacco Coordination Center VOF, Atlas Copco Airpower NV, Belgacom International Carrier Services NV, Dow Corning Europe NV/SA, Pfizer Animal Health SA, Wabco Europe BVBA, Celio International NV, and Bridgestone Europe NV.
The announcement comes a day before Apple Inc. fights another tax battle with the EU at the same court, hoping it can also overturn an order to pay back billions of euros. Starting new probes in a case the EU thought it had wrapped up in 2016 shows the determination of Margrethe Vestager, the EU‘s antitrust chief, to push on with a corporate crackdown. She’s been tasked with drafting new digital tax rules if global reforms dont make progress.
The EU‘s General Court threw out the initial tax investigation in February, saying regulators had failed to show the 39 firms were part of a specific tax program. The new investigations avoid that issue by probing each deal individually. The commission says the “excessive profit” rulings resulted in exempting the companies’ accounting profit from tax by more than 50% and sometimes up to 90%.
— With assistance by Chris Elser
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.